At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ABOS Acumen Pharmaceuticals, Inc.
Market Closed 10-25 16:00:00 EDT
2.90
+0.16
+5.84%
盘后2.83
-0.07-2.41%
19:19 EDT
High3.03
Low2.75
Vol299.45K
Open2.75
D1 Closing2.74
Amplitude10.22%
Mkt Cap174.23M
Tradable Cap94.01M
Total Shares60.08M
T/O870.55K
T/O Rate0.92%
Tradable Shares32.42M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BRIEF-Acumen Pharmaceuticals To Deliver Late-Breaking Presentation At 17Th Annual Clinical Trials On Alzheimer’S Disease (Ctad) Conference
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.